1. Home
  2. LIPO vs ATXG Comparison

LIPO vs ATXG Comparison

Compare LIPO & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIPO
  • ATXG
  • Stock Information
  • Founded
  • LIPO 2005
  • ATXG 2014
  • Country
  • LIPO United States
  • ATXG China
  • Employees
  • LIPO N/A
  • ATXG N/A
  • Industry
  • LIPO Biotechnology: Pharmaceutical Preparations
  • ATXG Professional Services
  • Sector
  • LIPO Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • LIPO Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • LIPO 3.8M
  • ATXG 3.9M
  • IPO Year
  • LIPO 2022
  • ATXG N/A
  • Fundamental
  • Price
  • LIPO $2.85
  • ATXG $0.71
  • Analyst Decision
  • LIPO Strong Buy
  • ATXG
  • Analyst Count
  • LIPO 1
  • ATXG 0
  • Target Price
  • LIPO $16.00
  • ATXG N/A
  • AVG Volume (30 Days)
  • LIPO 91.5K
  • ATXG 34.8K
  • Earning Date
  • LIPO 02-25-2025
  • ATXG 02-12-2025
  • Dividend Yield
  • LIPO N/A
  • ATXG N/A
  • EPS Growth
  • LIPO N/A
  • ATXG N/A
  • EPS
  • LIPO N/A
  • ATXG N/A
  • Revenue
  • LIPO $483,533.00
  • ATXG $4,958,444.00
  • Revenue This Year
  • LIPO N/A
  • ATXG N/A
  • Revenue Next Year
  • LIPO N/A
  • ATXG N/A
  • P/E Ratio
  • LIPO N/A
  • ATXG N/A
  • Revenue Growth
  • LIPO 0.78
  • ATXG N/A
  • 52 Week Low
  • LIPO $2.21
  • ATXG $0.49
  • 52 Week High
  • LIPO $12.00
  • ATXG $1.77
  • Technical
  • Relative Strength Index (RSI)
  • LIPO 45.72
  • ATXG 54.07
  • Support Level
  • LIPO $2.78
  • ATXG $0.58
  • Resistance Level
  • LIPO $3.17
  • ATXG $0.78
  • Average True Range (ATR)
  • LIPO 0.29
  • ATXG 0.10
  • MACD
  • LIPO -0.04
  • ATXG -0.00
  • Stochastic Oscillator
  • LIPO 7.61
  • ATXG 46.53

About LIPO Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: